Ronovo Surgical, Inc.

Have updates for this profile? Please contribute data

= Subscriber Access Only

You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.

With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.

Ronovo Surgical, Inc. - overview

Established

2019

Location

Shanghai, -, China

Primary Industry

Medical Devices & Equipment

About

Established in 2019, and based in Shanghai, China, Ronovo Surgical is a medical medical technology that focuses on the research and development of surgical robots. The team members have worked at Johnson & Johnson, Medtronic, and KUKA. In early 2025, Ronovo Surgical raised series C funding led by Granite Asia. In September 2025, Ronovo Surgical raised USD 67 million of Series D funding from Johnson & Johnson Innovation, including Lilly Asia Ventures, Granite Asia, and INCE Capital.


The company is committed to providing minimally invasive surgical robots and digital surgery solutions for hospitals. The products include laparoscopic surgical robot systems, endoscopic imaging systems, surgical instruments, etc. The modular surgical robots have passed type inspection and GLP (Good Laboratory Practice) animal experiments. The company generates revenue by providing minimally invasive surgical robots and digital surgery solutions.


The organization plans to use the September 2025 funding to further advance innovation in surgical medical technology and expand its market presence.


Current Investors

Lilly Asia Ventures, Vivo Capital, MPCi

Primary Industry

Medical Devices & Equipment

Sub Industries

Healthcare IT, Diagnostic Equipment, Surgical Devices, Medical Software

Website

www.ronovosurgical.com/

Verticals

Manufacturing, Robotics

Company Stage

Series D

Total Amount Raised

Subscriber access only

GoingPro

Time to go Pro

Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.